Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: November 8, 2023
Reporting Period: The filing announces financial results for the three months ended September 30, 2023, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data. The filing references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for these metrics.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It serves only to notify the market of the issuance of the Q3 2023 press release.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the Company issued a press release on November 8, 2023, announcing results for the three months ended September 30, 2023.
Legal Disclaimer: The information in this report and its exhibits is not incorporated by reference into other filings and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Guidance/Risks: No specific guidance, outlook, risks, or contingencies are detailed in the text of this 8-K form.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 8, 2023) for actual Q3 2023 financial figures.
- Verify the Company's status as an emerging growth company (indicated as "Yes" in the filing).
- Confirm the trading symbol (INBS) and exchange (The Nasdaq Stock Market LLC).
- Check for any subsequent filings that may incorporate the press release by reference.